Where To Invest Now For High Returns

Money Info Show

Investment News Show

Money Info Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show

LISTEN LIVE

Use this Link To Watch The Show:

www.princetonresearch.com/money-info-live.htm

Be On The Air With Us
Call In Your Questions
888-792-1590

 

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

The show is broadcast live on the internet and on the air  from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast 

Money Info is hosted by investing experts Mike King, Charles Moskowitz and Gary Cella together with radio broadcasting professional Greg Wyatt.

Watch Money Info

Investment News Show Replays

 

November 29, 2016 Show:

3D Printer Stock News on Investing News Show

The November 29th Show features 3D Printer Technology Stock

Mark Cola, CEO of Sigma Labs

and an interview with CEO Mark Cola

3D Printer Stock News

See Sigma Corporate Site

See Investors Information Page

Get SGLB Stock Quote

 

Listen to a replay of the interview:

Sigma labs is a provider of 3D printing products and services, including quality assurance software and contract printing services in a variety of industries: aerospace, healthcare, automotive, and consumer products.

3D Printer Stock News

Sigma Labs partners with 3-D printing giant

Sigma Labs has signed a deal to work with one of the giants in the 3-D printing space, contracting to work with Siemens Industrial Turbomachinery AB of Sweden. — See News Release 

Siemens contacted the company earlier this year about helping with quality assurance as its 3-D manufacturing demand grows. Sigma will provide statistical process control and assure part quality for Siemens burner repairs and set the stage for productivity optimization.

“We are very delighted,” Cola said about the new deal. “This is a perfect fit for Sigma Labs.”

Small Cap 3D Printer Tech Stocks

Sigma Labs, Inc. comprises leading scientists and engineers from Los Alamos National Laboratory with over 100 years of combined industrial R&D experience. They develop manufacturing and materials technologies and R&D solutions for first-tier integrators like Boeing, GE Aviation, Honeywell Aerospace, and other commercial firms around the globe. Sigma Labs, Inc. has current contracts with Federal Government and private industry clients to develop technologies from their conception through the design, building, and testing of prototype systems by integrating sensing, software, materials, and manufacturing technology risk-reduction solutions.

 

November 29, 2016 Show:

Small Cap Undervalued Stocks

On Investment News Show

Medical Products Stock News

The November 29th show features Medical Waste disposal products stock

Skyline Medical, Inc. (stock symbol: SKLN) and an interview with

Peter Alex

VICE PRESIDENT OF SALES

Listen to a replay of the interview:

Mr Alex discuss the benefits of Skyline medical waste disposal system and

recent news that

Skyline Medical Receives Health Canada Approval to Market STREAMWAY® System

Expects nationwide distribution to be in place in the next few weeks

Nov. 22, 2016 Skyline Medical Inc. producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that it has received a Medical Device Establishment License to sell the STREAMWAY System and related disposables in Canada.

A number of distributors have expressed interest in selling STREAMWAY into Canada’s healthcare system.  Skyline has now begun talks with several of them and expects within the next few weeks to come to terms with one or more distributors, covering approximately 1,500 hospitals in all 13 provinces of Canada.

“We look forward to bringing the STREAMWAY System and its many benefits to healthcare professionals and facilities to the approximately 10,000 operating rooms across Canada,” said Dr. Carl Schwartz, executive chairman of Skyline Medical. “This approval follows receipt of ISO 13485:2003 certification for the STREAMWAY System, which not only was a requirement for Canadian approval, but is necessary for the CE Mark and subsequent sales in the European Union. We are pleased to reach this important milestone in our plans for broader distribution of the STREAMWAY System.”

See Full Press Release

Medical Waste Management Stock News

See corporate site: SkylineMedical.com

Get SKLN stock quote

See Investors Information Resources Page

 

See Latest Company News

 

Peter Alex – VICE PRESIDENT OF SALES

Mr. Alex was appointed VP of Sales in July 2016. He has nearly 20 years of commercial medical device experience with industry leaders including Olympus Corporation and Boston Scientific Corporation, as well as with emerging companies, and a career-long focus on gastroenterology, pulmonary and surgical endoscopic products. Prior to Skyline Medical, Pete served as a National Sales Director at Olympus Corporation where he led two product launches and managed product life cycle efforts. Prior to Olympus, he served as Vice President of Sales and Marketing for Somna Therapeutics, a startup medical device company for which he co-invented the Reza Band™. Prior to Somna, Pete worked at Olympus Corporation from 2003 to 2012, holding sales and marketing roles of increasing responsibility, and at Boston Scientific from 2001 to 2003 as Territory Manager for Microvasive Endoscopy. Mr. Alex has an MBA from Marquette University and a BS in Economics from University of Wisconsin-Milwaukee

 

 

Skyline Medical Signs Agreement for GLG Pharma to be Exclusive Distributor of STREAMWAY System in the U.K.See News

GLG to Begin Sales and Marketing Immediately upon Receipt of CE Mark

Skyline Medical Inc. producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a distribution agreement granting GLG Pharma, LLC (“GLG”) exclusive rights to market and distribute the STREAMWAY® System in the U.K.

Under the terms of the agreement, GLG will be responsible for all sales and marketing activities, including hiring and training the appropriate number of direct sales representatives to cover the 3,600 operating rooms in the U.K.

Medical stocks to buy

 

The new standard in waste fluid management.

Skyline Medical developed the patented, FDA-approved STREAMWAY System, which simplifies and improves the management of surgical fluid for the benefit of patients, staff and the environment.

 

The revolutionary, FDA-approved STREAMWAY® System is an automated, direct-to-drain system that’s changing the way healthcare facilities collect and dispose of potentially infectious waste fluid.

 

Skyline Medical produces a fully automated, patented, FDA-cleared waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment.

 

Antiquated manual fluid handling methods that require hand carrying and emptying filled fluid canisters present an exposure risk and potential liability.

 

Skyline Medical’s STREAMWAY System medical product fully automates the collection, measurement and disposal of waste fluids and is designed to:

1) reduce overhead costs to hospitals and surgical centers;

2) improve compliance with OSHA and other regulatory agency safety guidelines;

3) improve efficiency in the operating room, and radiology and endoscopy departments, thereby leading to greater profitability; and

4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills each year in the U.S.

Medical waste management stocks

 

Medical Waste Management Products News

small cap medical products stocks

The STREAMWAY System installs in or on the wall with direct-to-drain fluid removal medical product for safe, continuous collection and disposal. The illuminated touch screen provides safe control over surgical suction levels and displays automated measurement of volumes, while the single patient procedure filter and tissue trap both prevents cross contamination and allows for tissue retrieval. To clean, simply detach the filter, connect the cleaning solution bottle and activate the rapid clean cycle using the touch screen.

 

 

Investment News Show

November 8, 2016 Show:

 

Undervalued Medical Stocks

on

Investment News Show 

The show features an interview with

Ric Schumacher, President of

Pressure Biosciences, Inc.

(Stock Symbol: PBIO)

Lab Instruments Medical Products Stock

Listen to a replay of the Interview:

 

The Show Also Features 

Texas Oil and Gas investing News

Live Interview with Tim Connolly of Texas Gulf Oil

oil investing May 2016

Tim discusses undervalued oil & gas stocks and where to invest now in the oil & gas sector.

 

Hear Part 1 of the show, with oil and gas investing news from Tim Connolly:

 

See corporate site: PressureBiosciences.com

Get PBIO Stock Quote

Lab Instruments Stock

See Executive Summary

See Latest Company Press Releases

 

Pressure BioSciences, Inc. (OTCQB: PBIO) is a life sciences tools company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on our game-changing Pressure Cycling Technology (“PCT”).

PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (up to 90,000 psi) to safely, conveniently and reproducibly control the actions of molecules in biological samples, e.g., the rupture (lysis) of cells and tissues from human, animal, plant, and microbial sources, and the inactivation of pathogens.

Lab Instruments Company

See Pressure BioSciences Life Sciences Lab Instruments Products Page

Pressure BioSciences, Inc. (“PBI”) (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions.

To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use our products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.

 

Where to Invest now in the Oil & Gas Industry

 

Undervalued Medical Stocks

Investment News Show 

Medical Products Stock News

Medical Waste Disposal Products Stock

on Investment News Show

 

November 1, 2016 Show:

The November 1st show features Medical Waste disposla products stock

Skyline Medical, Inc. (stock symbol: SKLN) and interviews with:

 

Richard Gabriel,

Co-founder and Chief Operating Officer of GLG Pharma, LLC.

and 2 newly-appointed Skyline Medical board members

Timothy A. Krochuk and

J. Melville (“Mel”) Engle

 

Medical Waste Management Stock News

See corporate site: SkylineMedical.com

Get SKLN stock quote

See Investors Information Resources Page

 

See Latest Company News

 

Skyline Medical Appoints J. Melville Engle and Timothy A. Krochuk to its Board of Directors — See News

Skyline Medical Inc. producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the appointments of Timothy A. Krochuk and J. Melville (“Mel”) Engle to its Board of Directors.

“We are delighted to welcome such talented and experienced professionals as Tim and Mel to the Skyline Medical Board of Directors.  They bring to Skyline decades of valuable functional expertise and significant sector experience,” said Dr. Carl Schwartz, Executive Chairman of Skyline Medical. “We have full confidence their financial, pharmaceutical and leadership skills, together with their public company experience will be of true value to Skyline. These two additions bring depth to our governance, and we look forward to their contributions as we work together to execute our growth strategy.”

 

J. Melville Engle
Mr. Engle has worked in the healthcare industry for the past three decades.  He is Chairman of the Board of Windgap Medical, Inc., a start-up medical device firm focused on unique drug delivery applications, and has held executive positions at prominent companies including Chairman and Chief Executive Officer at ThermoGenesis Corp., Regional Head/Director, North America at Merck Generics, President and Chief Executive Officer of Dey, L.P. and Senior Vice President, U.S. Sales at Allergan.

In addition to ThermoGenesis, he has served on the Board of Directors of several public companies, including Oxygen Biotherapeutics and Anika Therapeutics.

 

Timothy A. Krochuk
Mr. Krochuk is a co-founder and Managing Director of GRT Capital Partners, LLC, an investment adviser based in Boston, and is a Portfolio Manager and Managing Partner for the GRT BioEdge Ventures Fund, a fund focused on equity investments in privately held, emerging healthcare and biopharmaceutical companies. 

He currently serves as Chief Executive Officer of CHP Clean Energy, a full-service provider of biogas powered combined heat and power systems for wastewater treatment facilities with anaerobic digesters, which he founded in 2009.  He also serves on the Board of Directors of Windgap Medical and Flatirons Bank.

 

Skyline Medical Signs Agreement for GLG Pharma to be Exclusive Distributor of STREAMWAY System in the U.K.See News

GLG to Begin Sales and Marketing Immediately upon Receipt of CE Mark

Skyline Medical Inc. producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a distribution agreement granting GLG Pharma, LLC (“GLG”) exclusive rights to market and distribute the STREAMWAY® System in the U.K.

Under the terms of the agreement, GLG will be responsible for all sales and marketing activities, including hiring and training the appropriate number of direct sales representatives to cover the 3,600 operating rooms in the U.K.

Medical stocks to buy

 

The new standard in waste fluid management.

Skyline Medical developed the patented, FDA-approved STREAMWAY System, which simplifies and improves the management of surgical fluid for the benefit of patients, staff and the environment.

 

The revolutionary, FDA-approved STREAMWAY® System is an automated, direct-to-drain system that’s changing the way healthcare facilities collect and dispose of potentially infectious waste fluid.

 

Skyline Medical produces a fully automated, patented, FDA-cleared waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment.

 

Antiquated manual fluid handling methods that require hand carrying and emptying filled fluid canisters present an exposure risk and potential liability.

 

Skyline Medical’s STREAMWAY System medical product fully automates the collection, measurement and disposal of waste fluids and is designed to:

1) reduce overhead costs to hospitals and surgical centers;

2) improve compliance with OSHA and other regulatory agency safety guidelines;

3) improve efficiency in the operating room, and radiology and endoscopy departments, thereby leading to greater profitability; and

4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills each year in the U.S.

Medical waste management stocks

 

Medical Waste Management Products News

small cap medical products stocks

The STREAMWAY System installs in or on the wall with direct-to-drain fluid removal medical product for safe, continuous collection and disposal. The illuminated touch screen provides safe control over surgical suction levels and displays automated measurement of volumes, while the single patient procedure filter and tissue trap both prevents cross contamination and allows for tissue retrieval. To clean, simply detach the filter, connect the cleaning solution bottle and activate the rapid clean cycle using the touch screen.

 

Undervalued Medical Stocks 

Medical Products Company Stock News

 

 

October 25, 2016 Show:

iSIGN Media Corp.

Interactive Mobile Advertising Stock

on Investment News Show

The October 25th show features an interview with

Alex Romanov
President & Chief Executive Officer, Director of

iSIGN Media Corp.

Stock Symbol:

ISD TSX

ISDSF (US Markets)

 

Hear a replay of the interview:

 

Hear a replay of Part 1 of the show:

 

See corporate site: iSignMedia.com

Get iSign Media Stock Quote

See Corporate Information Page 

See Latest Company NEWS

 

 

iSIGN Media Corp.

Interactive Marketing Solutions Stock

iSIGN Media a leading provider of interactive mobile advertising solutions that serves brands, commercial locations, retailers and service providers throughout North America.

ISIGN Media is a pioneer software-as-a-service (SaaS) company, gathering point-of-sale data and mobile shopper preferences to generate actionable data and reveal valuable consumer insights.

Creators of the Smart Antenna, an interactive proximity marketing technology, iSIGN enables brands to deliver targeted messaging, personalized offers and loyalty perks to consumer mobile devices on location and in real-time.

 

They have announced a signed contract between their reseller We Build Apps, LLC (“WBA”), and a major shopping complex for 500 Smart Antennas. The  anticipated minimum revenue to iSIGN is $2.7 million Canadian. SEE NEWS

 

iSIGN advertising is proximity advertising. Research shows that consumers receiving an ad within proximity to a retailer are far more likely to act on the ad. This is attributed to the fact that very little user work is required to act upon the impulse to purchase what the ad supports.  Other important benefits include:

Polling. Get consumer feedback on products in real-time.

Product details and Menu boards. Give users the ability to view detailed product info. Info can include menu boards that user’s can interact with to order product.

Wayfinding. Discover user location via Wi-Fi and Bluetooth and provide real time directions from their location to a destination within a map.

Loyalty Programs. Track loyalty members using Wi-Fi and Bluetooth to provide targeted advertising based on location history or member-selected categories.

The Bottom Line:

  • The cost of engaging a consumer at any time is $.03 or less which is significantly lower than print.
  • Unlike a bill board the consumer is in the store.
  • It is free to the consumer.
  • Allows advertising agencies to differentiate themselves since our experience has shown the better the content the greater the participation.
  • The system is easy to use and requires no capital to implement.
  • Can be a source of significant revenue for the retailer.
  • The back office analyzes data and results in real time and the output is customizable.

Fast – Flexible – Economic – Measurable – Accountable – Effective

Interactive Marketing Solutions Stock News

iSIGN Media Corp.’s patent pending Interactive Marketing Solution (IMS 3.1) provides businesses with an effective and easy to use content delivery vehicle combined with real time data capturing to provide the perfect business intelligence tool. Our complete IMS offering including our patent pending software and smart antenna makes location based interactive proximity advertising to mobile devices measurable, accountable, flexible and affordable.

Interactive Marketing Solutions Stock News

Software-as-a-service (SaaS) Company Stock News

Announces Signed Contract Between We Build Apps and a Major Shopping Complex Located in Ohio. The contract covers installation of 500 Smart Antennas into a first Shopping Complex; Minimum Revenue to iSIGN is $2.7 million Canadian.

 

According to the iSign Media reseller, JEA Technologies, eHealth Consortium Group’s intention is to start installations in hospitals located in the State of Victoria.

Interactive Marketing Solutions Stock

Alex Romanov President & Chief Executive Officer, Director

Alex Romanov, CEO, has enjoyed a diverse work life rich in experience. He worked with industry leaders in his formative years, such as Motorola where he learned how to build and run a business. He then ported that expertise to Alpine Electronics, where for 16 years, with his leadership team, he built that organization into an industry leader. At Alpine Electronics, which was a direct subsidiary of Alps Electric Japan, he established the Canadian operation and in three short years grew the brand to enjoy #1 market share deposing then industry leaders Pioneer and Kenwood. Hand in hand with Alpine’s growth as a premium brand, Mr. Romanov, established and grew its OEM business, establishing Alpine standard equipment in BMW, Honda, Lamborghini and other automotive icons. After leaving Alpine in 1996 Mr. Romanov established his own marketing agency, bringing leading consumer electronic brands such as AST Computers into his portfolio and establishing sales and distribution for them, again winning the top market share for them over then industry giants Compac, IBM and Packard Bell. Mr. Romanov lead the acquisition team when Alpine acquired Luxman home audio, and parlayed this experience complimented by his rich experience later in his career as he developed and co-founded Spherex Inc., which developed and marketed an Xbox gaming audio system. Spherex was sold to a US concern in 2005. Alex has been iSIGN’s Chief Executive Officer since November 2007 and has successfully restructured the company, positioning it for rapid growth worldwide.

 

 

 

October 17, 2016 Show:

The October 17, 2016 Money Info Investing News show features live interview with medical products stock:

RMS Medical Systems, Inc.

(Stock Symbol: REPR)

Chairman of the Board 

Andrew Sealfon

Hear a replay of the interview:


Hear a replay of Part 1 of the show:

 

Medical Stocks To Buy

RMS Medical Products is a U.S. manufacturer of medical devices which maintains offices and manufacturing facilities in Chester, NY. They employ 60 people. For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies.

Principal products include  the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.

 

Visit the corporate website: RMSMedicalProducts.com

 

Click Here For REPR stock quotes,

trading charts and latest news releases

 

See RMS Medical Investors Information Page

with financials

 

The Company manufactures medical products used for infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60(R) and the newer FreedomEdge™ Syringe Infusion Pumps, RMS Precision Flow Rate Tubing(TM) and RMS HIgH-Flo(TM) Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers.

NHIA is a trade association representing the interests of entities providing infusion and specialty pharmacy products and services to home-based infusion patients.

Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.

 

The Freedom60 has a proprietary technology

that makes it desirable for the

delivery of medications in a wide variety of  therapies.

Medical Products Stock news

It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.

This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60.

under valued medical products stock

 

Improves  quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.

 

RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.

 

 

RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event of disasters where power is lost because it doesn’t require electricity.

 

top medical products stock

 

The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles,  which are considerably less painful when entering the skin.

 

 

 

October 11, 2016 Show:

iSIGN Media Corp.

Interactive Marketing Solutions and

Software-as-a-service (SaaS) company

on Investment News Show

The October 11th show features an interview with

Alex Romanov
President & Chief Executive Officer, Director of

iSIGN Media Corp.

Stock Symbol:

ISD TSX

ISDSF (US Markets)

See corporate site: iSignMedia.com

Get iSign Media Stock Quote

See Corporate Information Page 

See Latest Company NEWS

 

Hear a Replay of the Interview on the show:

 

 

iSIGN Media Corp.

Interactive Marketing Solutions Stock

iSIGN Media, based in Toronto, is a data-focused, software-as-a-service (SaaS) company that is a pioneer in gathering point-of-sale data and mobile shopper preferences to generate actionable data and reveal valuable consumer insights.

 

Creators of the Smart Antenna, an interactive proximity marketing technology, iSIGN enables brands to deliver targeted messaging, personalized offers and loyalty perks to consumer mobile devices on location and in real-time.

iSIGN’s data gathering capabilities provide analytics on price points, typical purchases, in-store dwell time and other shopper metrics that identify emerging consumer behaviors. These insights enable smarter business decisions and provide ROI metrics for more transparent marketing. iSIGN delivers relevant, timely messages on an opt-in basis at no charge to consumers, transmitting rich media to consumer mobile devices via trusted, mature Bluetooth® and WiFi technologies without the restrictions associated with iBeacon. Proven to increase brand engagement and customer loyalty, iSIGN generates preference-based, predictive “clean data” without compromising consumer privacy.

Interactive Marketing Solutions Stock News

iSIGN Media Corp.’s patent pending Interactive Marketing Solution (IMS 3.1) provides businesses with an effective and easy to use content delivery vehicle combined with real time data capturing to provide the perfect business intelligence tool. Our complete IMS offering including our patent pending software and smart antenna makes location based interactive proximity advertising to mobile devices measurable, accountable, flexible and affordable.

Interactive Marketing Solutions Stock News

Software-as-a-service (SaaS) Company Stock News

Announces Signed Contract Between We Build Apps and a Major Shopping Complex Located in Ohio. The contract covers installation of 500 Smart Antennas into a first Shopping Complex; Minimum Revenue to iSIGN is $2.7 million Canadian.

Recent news has pushed it above its 30 day moving average and it had exceeded $0.15 Canadian on a high volume breakout. The stock has been disappointing failing to move above its next resistance at $0.20 and move towards its 2 yr high of $0.28.

The Crocker people and their 22 developments could bring iSign significant revenues. Homeland Security and a major insurance company deemed the smart antenna as a safety device as well as a security device making the potential for new markets is limitless. One deal brings in 3 million times that by 20 deals because the insurance company theoretically gives a 20-25% premium discount to companies that use the smart antenna.

According to the iSign Media reseller, JEA Technologies, eHealth Consortium Group’s intention is to start installations in hospitals located in the State of Victoria.

Interactive Marketing Solutions Stock

Alex Romanov President & Chief Executive Officer, Director

Alex Romanov, CEO, has enjoyed a diverse work life rich in experience. He worked with industry leaders in his formative years, such as Motorola where he learned how to build and run a business. He then ported that expertise to Alpine Electronics, where for 16 years, with his leadership team, he built that organization into an industry leader.

At Alpine Electronics, which was a direct subsidiary of Alps Electric Japan, he established the Canadian operation and in three short years grew the brand to enjoy #1 market share deposing then industry leaders Pioneer and Kenwood. Hand in hand with Alpine’s growth as a premium brand, Mr. Romanov, established and grew its OEM business, establishing Alpine standard equipment in BMW, Honda, Lamborghini and other automotive icons.

After leaving Alpine in 1996 Mr. Romanov established his own marketing agency, bringing leading consumer electronic brands such as AST Computers into his portfolio and establishing sales and distribution for them, again winning the top market share for them over then industry giants Compac, IBM and Packard Bell. Mr. Romanov lead the acquisition team when Alpine acquired Luxman home audio, and parlayed this experience complimented by his rich experience later in his career as he developed and co-founded Spherex Inc., which developed and marketed an Xbox gaming audio system. Spherex was sold to a US concern in 2005.

Alex has been iSIGN’s Chief Executive Officer since November 2007 and has successfully restructured the company, positioning it for rapid growth worldwide.

 

 

 

Interactive Marketing Solutions Stock News

Software-as-a-service (SaaS) company Stock News

 

October 4, 2016 Show:

Life Sciences Company 

Lab Instruments Stock

on Investment News Show

The October 4th show features an interview with

Ric Schumacher, President of

Life Sciences Laboratory Instruments

Products Company

Pressure Biosciences, Inc.

(Stock Symbol: PBIO)

Listen to a replay of the Interview:

 

Hear Part 1 of the show, with oil and gas investing news from Tim Connolly:

 

See corporate site: PressureBiosciences.com

Get PBIO Stock Quote

Lab Instruments Stock

See Executive Summary

See Latest Company Press Releases

 

Pressure BioSciences, Inc. (OTCQB: PBIO) is a life sciences tools company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on our game-changing Pressure Cycling Technology (“PCT”). PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (up to 90,000 psi) to safely, conveniently and reproducibly control the actions of molecules in biological samples, e.g., the rupture (lysis) of cells and tissues from human, animal, plant, and microbial sources, and the inactivation of pathogens.

Lab Instruments Company

See Pressure BioSciences Life Sciences Lab Instruments Products Page

Pressure BioSciences, Inc. (“PBI”) (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use our products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.

 

September 27, 2016 Show: 

Undervalued Medical Stock

Medical Waste Management Stock News

on Investment News Show

The September 27th show features Medical Waste Management stock

Skyline Medical, Inc. (stock symbol: SKLN) and an interview with:

Dr. Carl Schwartz, Interim Chief Executive Officer

Bob Beringer, Chief Executive Officer of Electronic On-Ramp and

Richard Gabriel, Co-founder and Chief Operating Officer of GLG Pharma, LLC.

 

Hear a Replay of The Interview:

 

Hear a Replay of Part 1 of the Show:

 

Medical Waste Management Stock News

See corporate site: SkylineMedical.com

Get SKLN stock quote

See Investors Information Resources Page

 

See Latest Company News

Medical stocks to buy

Interview covers recent news that Skyline Medical has signed a partnership agreement with GLG, which intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures.

Medical stock news on the expected joint venture with Electronic On-Ramp to supply STREAMWAY to U.S. government mobile operating rooms, including disaster relief sites will also be discussed.

 

Skyline Medical and GLG Pharma Enter into Partnership to Develop Diagnostic Tests for Skyline’s STREAMWAY System

See full news release

Under the terms of the agreement, GLG intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures.  Skyline Medical will issue common stock to GLG in four separate tranches, with each tranche released after the achievement of certain development milestones.  In addition, Skyline will pay a royalty to GLG on the sale of individual tests.

Initial tests are anticipated to include cancer biomarkers and infectious diseases.  The oncology test panels will feature GLG’s patented inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3), which are in preclinical development for a new generation of targeted therapies.

The new standard in waste fluid management.

Skyline Medical developed the patented, FDA-approved STREAMWAY System, which simplifies and improves the management of surgical fluid for the benefit of patients, staff and the environment.

 

The revolutionary, FDA-approved STREAMWAY® System is an automated, direct-to-drain system that’s changing the way healthcare facilities collect and dispose of potentially infectious waste fluid.

 

Skyline Medical produces a fully automated, patented, FDA-cleared waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment.

 

Antiquated manual fluid handling methods that require hand carrying and emptying filled fluid canisters present an exposure risk and potential liability.

 

Skyline Medical’s STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to:

 

1) reduce overhead costs to hospitals and surgical centers;

2) improve compliance with OSHA and other regulatory agency safety guidelines;

3) improve efficiency in the operating room, and radiology and endoscopy departments, thereby leading to greater profitability; and

4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills each year in the U.S.

Medical waste management stocks

 

Medical Waste Management Stock News

Skyline Medical to Hold Business Update Conference Call on September 8th to discuss its proposed joint venture with Electronic On-Ramp and other corporate activities – See news

small cap medical products stocks

 

Dr. Carl Schwartz

Interim President And Chief Executive Officer, Director

Dr. Schwartz was appointed to Skyline Medical’s board of directors in March 2016, and became interim president and chief executive officer in May 2016.   He has owned and managed dental groups in Michigan, beginning with one practice in 1966, and overseeing its expansion into a 14-office practice when he left the active practice of dentistry in 1988. He currently owns two dental practices, in Burton, Mich. and Grand Blanc, Mich.

In 1988 Dr. Schwartz joined a family business, becoming chief executive officer of Plastics Research Corporation, a Flint, Mich. manufacturer of structural foam molding, a low pressure injection molding process.  While there, he led its growth from $2 million in revenues and 20 employees, to its becoming the largest manufacturer of structural foam molding products under one roof in the U.S. with more than $60 million in revenues and 300 employees when he retired in 2001.

Dr. Schwartz previously served on the board of Delta Dental Corporation of Michigan, was a member of the Michigan Advisory Board for Liberty Mutual Insurance and was a member of the Board of Trustees of the Museum of Contemporary Art in Florida.

He holds B.A. and D.D.S. degrees from the University of Detroit.

 

 

 

September 20, 2016 Show:

Undervalued Skin Care Products Stock

Sunscreen Product Stock

on Investment News Show

The September 20th undervalued stocks to buy and investing news show, Money Info, features:

Terry Howlett, 

President & CEO of

Skinvisible, Inc.

Stock Symbol: SKVI

Skin Products Stocks

SKINVISIBLE PHARMACEUTICALS, INC.

See Skinvisible Corporate Site — Skinvisible.com Click Here

Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance —Click Here

 

Sunscreen Products Stock News:

Skinvisible featured in Drug Development & Delivery journal

Skinvisible’s Kintari Launches New Addition to Product Line

See News – Skinvisible Inc., through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.

Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.

 

Skinvisible Pharmaceuticals is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing skin irritation. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. www.skinvisible.com, www.invisicare.com

Skin and Sunscreen Products Stocks

Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.

 

It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:

  • To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
  • To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
  • To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
  • To increase on-going revenues and profitability from current licensees.
  • To maximize shareholder value.

Sunscreen Products Stocks

Terry Howlett — President & Chief Executive Officer

Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.

Sunscreen Products Stocks

Sunscreen Products Stock NEWS

Skinvisible’s Kintari Launches New Addition to Product Line

Kintari’s Skincare Line Expands

April 6, 2016 Skinvisible Inc., (SKVI) through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.

Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.

SEE MORE

Anti-aging Skin care stocks

Skinvisible Expands Its Patent Portfolio with Comprehensive Acne Patent Adapalene, Retinoic Acid, Clindamycin and OTC Actives Now with IP Protection

Skinvisible Pharmaceuticals, Inc. (SKVI) a pharmaceutical research and development company with its proprietary skin delivery technology Invisicare(R), today announced that it has expanded its patent portfolio with a new patent granted by the United States Patent and Trademark Office entitled, “ACNE TREATMENT COMPOSITION AND METHODS FOR USING.”

“This patent is an important component of Skinvisible’s comprehensive intellectual property portfolio which includes sixteen patents that provide protection in the US and major international markets up to the year 2030. The granting of this patent recognizes the unique qualities of our Invisicare delivery technology. With the acne market generating over $5 billion in the U.S. last year, this new patent further enhances the value of our pipeline of products,” said Mr. Terry Howlett, President. “We are actively seeking a partner to license and advance the clinical development of our acne formulations and other prescription dermatology products.”

SEE MORE

Skinvisible’s Kintari Revolutionizes the Sunscreen Market Skinbrella(R) Officially Launched

Skinvisible Inc., through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella(R), a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.

sunscreen product stocks

 

August 16, 2016 Show:

Mining Stock News

on Investing News Show

 

August 16, 2016 Money Info Investing News show features live interview with

Phil Baker CEO of Hecla Mining (Stock Symbol:HL)

Hear a replay of Part 1 of the show:

 

Hear a replay of the Phil Baker HECLA MINING Interview:

 

Mining stock news

Corporate Web Site:  Hecla-Mining.com

Get Hecla Mining Stock Quote, Trading Charts and latest News:

USA mining stock news

Hecla Mining Company is

the largest and one of the lowest-cost U.S. silver producers,

the third largest U.S. producer of both zinc and lead,

and also a growing gold producer.

With four operating North American mines, a number of exploration properties and pre-development projects, a natural revenue hedge through the production of both precious and base metals, and its status as a growing gold producer, Hecla Mining Company is the largest primary silver producer in the U.S. – and the oldest NYSE-listed precious metals mining company in all of North America.

See Hecla Mining Investors Information Page

See Hecla Mining Investors Fact Sheet

USA mining stock news

Hecla Mining Company (NYSE:HL) is a primary leading, low-cost silver producer with operating silver mines in Alaska (Greens Creek), Idaho (Lucky Friday), and Mexico (San Sebastian) and is a gold producer with an operating mine (Casa Berardi) in Quebec, Canada. Expected 2016 silver production is 15.75 million ounces with expected gold production of 233,000 ounces.

In addition to its diversified silver and gold operating and cash-flow generating base, Hecla has a number of exploration properties and pre-development projects in six world-class silver and gold mining districts in North America. With an active exploration and development program, the company has consistently grown its reserve base for future production, with 2016 reserves totaling 175 million ounces of silver and 2.1 million ounces of gold reserves.

Established in 1891, Hecla is headquartered in Coeur d’Alene, Idaho, and has a sister office in Vancouver, B.C. The company’s common stock has been traded on the New York Stock Exchange for over 50 years.

Mining stock news

See Hecla Mining Stock News

August 9, 2016  Show

Small Cap Stocks To Buy 

Undervalued Medical Stock

on Investing News Show

 

August 9, 2016 Money Info Investing News show features live interview with small cap stock to buy:

RMS Medical Systems, Inc.

(Stock Symbol: REPR)

Chairman of the Board 

Andrew Sealfon

Medical Stocks To Buy

Hear a Replay of The Show (Interview Starts at 3 Minutes)

Part 1:

 

Part 2:

RMS Medical Products is a U.S. manufacturer of medical devices which maintains offices and manufacturing facilities in Chester, NY. They employ 60 people. For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies.

Principal products include  the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.

 

Visit the corporate website: RMSMedicalProducts.com

 

Click Here For REPR stock quotes,

trading charts and latest news releases

 

See RMS Medical Investors Information Page with financials —Click here 

 

 

The Company manufactures medical products used for infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60(R) and the newer FreedomEdge™ Syringe Infusion Pumps, RMS Precision Flow Rate Tubing(TM) and RMS HIgH-Flo(TM) Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers.

NHIA is a trade association representing the interests of entities providing infusion and specialty pharmacy products and services to home-based infusion patients.

Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.

 

Undervalued Small Cap Stocks To Buy News

 

Repro Med Systems, Inc. Posts Strong Revenue Growth,

Productivity Gains and Announces New Interim Chief Operating Officer

See News Release

 

The Freedom60 has a proprietary technology

that makes it desirable for the

delivery of medications in a wide variety of  therapies.

Medical Products Stock news

It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.

This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60.

under valued medical products stock

 

Improves  quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.

 

 

 

RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.

 

 

RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event of disasters where power is lost because it doesn’t require electricity.

 

top medical products stock

 

The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles,  which are considerably less painful when entering the skin.

 

August 2, 2016 Show:

 

Money Info Investing News Show

Show features Small Cap, undervalued

USA Battery Manufacturing Company

Live Interview with

Oakridge Global Energy Solutions:

The Only “Made in the USA” Lithium-Ion Battery

Steve Barber, Executive Chairman & CEO

 

 

Show Also Features Texas Oil and Gas investing News

Live Interview with 

Tim Connolly of Texas Gulf Oil

oil investing May 2016

Tim discusses Oil Investing in August 2016 including where to invest in Texas oil projects, oil price increase turn-around time frame and exciting opportunities created by oil price downturn.

About Tim Connolly

Tim is the Chairman, CEO, and founder of Texas Gulf Oil & Gas. Mr. Connolly is also the Managing Director and Founder of Corporate Strategies LLC, a private merchant banking firm based in Houston, Texas since 1984. Corporate Strategies portfolio companies have included interests in energy, technology, software development, defense electronics manufacturing, international nutritional products manufacturing and distribution, mobile device application development and other market segments, domestically and internationally.

Mr. Connolly has personally completed over $1 billion in transactions as principal, broker or adviser to banks, hedge funds, and investment partnerships both domestically and overseas.

 

 

Oakridge Global Energy Solutions:

Global Energy Solutions

Stock Symbol: OGES

See Corporate Site: OakG.net

See Investors Information Page with stock quotes

See OGES on Yahoo Finance

See Energy Stock Investors Information Report

 

Oakridge Global Energy Solutions, Inc. is an integrated, “made in USA”, energy storage solutions company that uses state-of-the-art technology to focus on making and developing advanced, high-quality cells, batteries, and power systems.

 

Their energy solutions are used in consumer, government, industrial, and military applications.

world energy solutions

The core business is in the design, development, and manufacturing of small to large format lithium ion cells, batteries, and battery systems.

Lithium-Ion Battery Energy Stock

Oakridge’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including Military, Aerospace, Marine, Industrial, Scientific and Telecom backup.

Small cap energy stocks

Oakridge’s technology team is strongly engineering driven, with core capabilities in materials, product design, process control, manufacturing technology, quality and safety.

Made in the USA Lithium-Ion Battery

 

Steve Barber: Chief Executive Officer

Steve Barber has over 30 years of experience in the international business sector with dual qualifications in science and law, specializing in international corporate finance, mergers, and acquisitions, asset acquisitions, corporate restructuring, offshore financing structures and the creation of new ventures, as well as government regulatory matters and counterterrorism risk management (especially terrorism financing restructures) in a range of international jurisdictions.

Steve holds the degrees of B.App. Sc (University of Southern Queensland), LL.B. & LL.M. (University of Adelaide), and an M.A. (Diplomacy) from Norwich University (VT).

Steve has resided in Australia, the U.S., and Canada, and his entrepreneurial approach and strength at building long term strategic alliances, coupled with his dual technical and corporate finance/law background equips him with the skill-sets necessary to bridge the gap between technical, operational, commercial, and government regulatory aspects required to create a dynamically successful, strategically focused business.

small cap US Energy Stocks

US Lithium-Ion Battery Producer

Oakridge is the poster child for the “Made in USA” movement and leads the charge in onshoring jobs and manufacturing back to America.

It manufactures hi-tech, leading edge, high quality, lithium ion batteries for high margin, niche consumer markets – golf cars, remote control cars, boats, drones and planes, home energy storage and living space power units for RVs, boats and interstate trucks, and starter motor batteries for “big boys toys” such as Harley Davidsons, jet skis, snow mobiles and boats – all cost competitive because of high quality, state of the art, automated US manufacturing techniques.

In an increasingly “unwired” world, batteries are THE recession proof product !

 

Energy Stock: USA Lithium Battery Manufacturer

Oakridge Global Energy Solutions is a publicly traded company, listed as OGES on the OTC, whose primary business is the manufacturing and marketing of products incorporating lithium battery technologies. The lithium batteries are constructed of lithium ion compounds that provide higher power, longer life, and are lighter weight than traditional batteries. These batteries can be employed in a broad range of commercial and government applications and incorporate a proprietary technology which enhances the safe operation of the battery.

 

Undervalued USA Energy Stock 

Investor Highlights

Oakridge Global Energy Solutions is headquartered in Melbourne Florida. We are operating a 12000 square foot battery development, a 24,000 square foot warehouse facility, and a 50,400 square foot manufacturing facility presently employing 24 full time staff members. The manufacturing plant is equipped with state of the art fabrication and manufacturing equipment for Lithium Ion batteries. The development facility is equipped with state of the art laboratory equipment including: chemistry lab, mixing operation, characterization and testing laboratories, scanning electronic microscope, and 3D color Keyence digital microscope. We have all of the necessary test and fabrication equipment to develop battery cells and systems from raw material to final product with full testing and performance validation.

 

Major Objectives

Oakridge Global Energy Solutions is continuing to develop and manufacture standard off-the-shelf products for various industries as needed to meet client’s needs. The sales force will continue to interface with existing and potential clients to pursue opportunities in commercial and government markets. The development and manufacturing facilities will be optimized for the production of product as needed to meet client delivery requirements. Additional technical and administrative staff will be hired to support development and production as needed.

 

 

Investment Highlights

 

  • Batteries made in USA using a proprietary lithium chemistry
  • Lithium batteries produced are comparable in price to traditional lead-acid

batteries, but charge faster, last longer and are much lighter.

  • Rapidly expanding workforce, and has been approved for nearly $9 million in

property tax breaks from Brevard County

  • Confirmed orders of $19.3 million backlogged in the US
  • Additional orders of $50 million in the US and Australia that are awaiting firm

delivery schedule

  • Further $110 million of orders from Japan awaiting firm delivery schedule
  • Primary shareholder (90 percent) is Precept Fund Management SPC
  • Oakridge Global Energy Solutions owns 11,000,000 shares of Leclanché S.A., a

Swiss developer and producer of energy storage systems

  • Filed for NASDAQ main board listing on July 31, 2015

 

Small Cap Energy Stocks To Buy

Undervalued Energy Stock News

Small Cap Stocks To Buy Investment News Show 

 

 

Be On The Air With Us
Call In Your Questions
888-792-1590

 

June 28 Show:

June 28th Money Info Investing News show will feature live interview with:

RMS Medical Systems, Inc.

(Stock Symbol: REPR)

Chairman of the Board 

Andrew Sealfon

Medical Stocks To Buy

Hear a replay of the show:

Andrew Sealfon Interview starts at 25 minutes

RMS Medical Products is a U.S. manufacturer of medical devices which maintains offices and manufacturing facilities in Chester, NY. They employ 60 people. For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies.

Principal products include  the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.

 

Visit the corporate website: RMSMedicalProducts.com

Click Here For REPR stock quotes,

trading charts and latest news releases

See RMS Medical Investors Information Page with financials —Click here 

Fourth quarter preliminary net revenues will exceed $3.2 million, representing a slight increase over the $3.1 million of the previous quarter.   Sales are led by the Company’s proprietary infusion products.  The Company’s fiscal year ended February 29, 2016.

Andy Sealfon, Company President and CEO commented, “The military has expressed interest in our products for utilization in emergency applications as well as use in VA hospitals.  We believe that because of our performance standards and the reliability of our products, we will provide them with great value and benefits.”

The Company manufactures medical products used for infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60(R) and the newer FreedomEdge™ Syringe Infusion Pumps, RMS Precision Flow Rate Tubing(TM) and RMS HIgH-Flo(TM) Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers.

NHIA is a trade association representing the interests of entities providing infusion and specialty pharmacy products and services to home-based infusion patients.

Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.

 

Undervalued Small Cap Medical Stock News

Repro Med Systems, Inc. Posts Strong Revenue Growth,

Productivity Gains and Announces New Interim Chief Operating Officer

See News Release

 

The Freedom60 has a proprietary technology

that makes it desirable for the

delivery of medications in a wide variety of  therapies.

Medical Products Stock news

It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.

This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60.

under valued medical products stock

 

Improves  quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.

RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.

RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event of disasters where power is lost because it doesn’t require electricity.

 

top medical products stock

The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles,  which are considerably less painful when entering the skin.

 

Undervalued Medical Stock
on Investing News Show

June 21, 2016 Show:

Undervalued Skin Products Stock

Sunscreen Product Stocks

on Investment News Show

The June 21 small cap stocks to buy and investing news show, Money Info, features:

Terry Howlett, 

President & CEO of

Skinvisible, Inc.

Stock Symbol: SKVI

Skin Products Stocks

SKINVISIBLE PHARMACEUTICALS, INC.

See Skinvisible Corporate Site — Skinvisible.com Click Here

Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance —Click Here

Listen to a Replay of the show:

The interview starts at the 24:30 Minute mark.

Once the video starts, you can hover over bottom of video to get controls and move them to the start of the interview.

Undervalued Skin Products Stock

Skinvisible Sunscreen product ad featured in USA Weekend edition right below Melanoma article.

Skinvisible featured in Drug Development & Delivery journal

Skinvisible’s Kintari Launches New Addition to Product Line

See News – Skinvisible Inc., through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.

Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.

 

Skinvisible Pharmaceuticals is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing skin irritation. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. www.skinvisible.com, www.invisicare.com

Skin and Sunscreen Products Stocks

Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.

 

It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:

  • To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
  • To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
  • To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
  • To increase on-going revenues and profitability from current licensees.
  • To maximize shareholder value.

Sunscreen Products Stocks

Terry Howlett — President & Chief Executive Officer

Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.

Sunscreen Products Stocks

Sunscreen Products Stock NEWS

Skinvisible’s Kintari Launches New Addition to Product Line

Kintari’s Skincare Line Expands

April 6, 2016 Skinvisible Inc., (SKVI) through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.

Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.

SEE MORE

Anti-aging Skin care stocks

Skinvisible Expands Its Patent Portfolio with Comprehensive Acne Patent Adapalene, Retinoic Acid, Clindamycin and OTC Actives Now with IP Protection

Skinvisible Pharmaceuticals, Inc. (SKVI) a pharmaceutical research and development company with its proprietary skin delivery technology Invisicare(R), today announced that it has expanded its patent portfolio with a new patent granted by the United States Patent and Trademark Office entitled, “ACNE TREATMENT COMPOSITION AND METHODS FOR USING.”

“This patent is an important component of Skinvisible’s comprehensive intellectual property portfolio which includes sixteen patents that provide protection in the US and major international markets up to the year 2030. The granting of this patent recognizes the unique qualities of our Invisicare delivery technology. With the acne market generating over $5 billion in the U.S. last year, this new patent further enhances the value of our pipeline of products,” said Mr. Terry Howlett, President. “We are actively seeking a partner to license and advance the clinical development of our acne formulations and other prescription dermatology products.”

SEE MORE

Skinvisible’s Kintari Revolutionizes the Sunscreen Market Skinbrella(R) Officially Launched

Skinvisible Inc., through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella(R), a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.

sunscreen product stocks

 

June 14, 2016:

The June 14th show features

USA Lithium-Ion Battery Manufacturing Company

Undervalued Energy Stock News

live interview with:

Oakridge Global Energy Solutions:

The Only “Made in the USA” Lithium-Ion Battery

Steve Barber, Executive Chairman & CEO

Global Energy Solutions

Stock Symbol: OGES

See Corporate Site: OakG.net

See Investors Information Page with stock quotes

See OGES on Yahoo Finance

See Energy Stock Investors Information Report

 

Oakridge Global Energy Solutions, Inc. is an integrated, “made in USA”, energy storage solutions company that uses state-of-the-art technology to focus on making and developing advanced, high-quality cells, batteries, and power systems.

 

Their energy solutions are used in consumer, government, industrial, and military applications.

world energy solutions

The core business is in the design, development, and manufacturing of small to large format lithium ion cells, batteries, and battery systems.

Lithium-Ion Battery Energy Stock

Oakridge’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including Military, Aerospace, Marine, Industrial, Scientific and Telecom backup.

Small cap energy stocks

Oakridge’s technology team is strongly engineering driven, with core capabilities in materials, product design, process control, manufacturing technology, quality and safety.

Made in the USA Lithium-Ion Battery

 

Steve Barber: Chief Executive Officer

Steve Barber has over 30 years of experience in the international business sector with dual qualifications in science and law, specializing in international corporate finance, mergers, and acquisitions, asset acquisitions, corporate restructuring, offshore financing structures and the creation of new ventures, as well as government regulatory matters and counterterrorism risk management (especially terrorism financing restructures) in a range of international jurisdictions.

Steve holds the degrees of B.App. Sc (University of Southern Queensland), LL.B. & LL.M. (University of Adelaide), and an M.A. (Diplomacy) from Norwich University (VT).

Steve has resided in Australia, the U.S., and Canada, and his entrepreneurial approach and strength at building long term strategic alliances, coupled with his dual technical and corporate finance/law background equips him with the skill-sets necessary to bridge the gap between technical, operational, commercial, and government regulatory aspects required to create a dynamically successful, strategically focused business.

small cap US Energy Stocks

US Lithium-Ion Battery Producer

Oakridge is the poster child for the “Made in USA” movement and leads the charge in onshoring jobs and manufacturing back to America.

It manufactures hi-tech, leading edge, high quality, lithium ion batteries for high margin, niche consumer markets – golf cars, remote control cars, boats, drones and planes, home energy storage and living space power units for RVs, boats and interstate trucks, and starter motor batteries for “big boys toys” such as Harley Davidsons, jet skis, snow mobiles and boats – all cost competitive because of high quality, state of the art, automated US manufacturing techniques.

In an increasingly “unwired” world, batteries are THE recession proof product !

 

Energy Stock: USA Lithium Battery Manufacturer

Oakridge Global Energy Solutions is a publicly traded company, listed as OGES on the OTC, whose primary business is the manufacturing and marketing of products incorporating lithium battery technologies. The lithium batteries are constructed of lithium ion compounds that provide higher power, longer life, and are lighter weight than traditional batteries. These batteries can be employed in a broad range of commercial and government applications and incorporate a proprietary technology which enhances the safe operation of the battery.

 

Undervalued USA Energy Stock 

Investor Highlights

Oakridge Global Energy Solutions is headquartered in Melbourne Florida. We are operating a 12000 square foot battery development, a 24,000 square foot warehouse facility, and a 50,400 square foot manufacturing facility presently employing 24 full time staff members. The manufacturing plant is equipped with state of the art fabrication and manufacturing equipment for Lithium Ion batteries. The development facility is equipped with state of the art laboratory equipment including: chemistry lab, mixing operation, characterization and testing laboratories, scanning electronic microscope, and 3D color Keyence digital microscope. We have all of the necessary test and fabrication equipment to develop battery cells and systems from raw material to final product with full testing and performance validation.

 

Major Objectives

Oakridge Global Energy Solutions is continuing to develop and manufacture standard off-the-shelf products for various industries as needed to meet client’s needs. The sales force will continue to interface with existing and potential clients to pursue opportunities in commercial and government markets. The development and manufacturing facilities will be optimized for the production of product as needed to meet client delivery requirements. Additional technical and administrative staff will be hired to support development and production as needed.

 

 

Investment Highlights

 

  • Batteries made in USA using a proprietary lithium chemistry
  • Lithium batteries produced are comparable in price to traditional lead-acid

batteries, but charge faster, last longer and are much lighter.

  • Rapidly expanding workforce, and has been approved for nearly $9 million in

property tax breaks from Brevard County

  • Confirmed orders of $19.3 million backlogged in the US
  • Additional orders of $50 million in the US and Australia that are awaiting firm

delivery schedule

  • Further $110 million of orders from Japan awaiting firm delivery schedule
  • Primary shareholder (90 percent) is Precept Fund Management SPC
  • Oakridge Global Energy Solutions owns 11,000,000 shares of Leclanché S.A., a

Swiss developer and producer of energy storage systems

  • Filed for NASDAQ main board listing on July 31, 2015

 

Small Cap Energy Stocks To Buy

Best Stocks To Buy Now Investing News Show Money Info

Undervalued Energy Stock News

 

 

Small Cap Stocks To Buy Investment News Show Replays

 

Money Info Show

Replay Archives

 

Hear Replays of

June 2016 to April 2016 Shows

HERE

 

Hear Replays of

March 2016 to January 2016 Shows

HERE

Hear Replays of 

December 2015 to October 2015 Shows

Click Here

September 13, 2016 Show:

 

Undervalued Energy Stock on Money Info Investing News Show

The September 13th Show features Small Cap, undervalued

energy stock and USA Battery Manufacturing Company

Live Interview with

Oakridge Global Energy Solutions:

The Only “Made in the USA” Lithium-Ion Battery

Steve Barber, Executive Chairman & CEO

 

Oakridge Global Energy Solutions:

Global Energy Solutions

Stock Symbol: OGES

Listen To Part 1 Replay of the Show with Texas Oil and Gas investing News

Live Interview with Tim Connolly of Texas Gulf Oil

:

 

Listen To Part 2 Replay of the Show with Steve Barber Oakridge Global Energy Solutions Interview:

See Corporate Site: OakG.net

See Investors Information Page with stock quotes

See OGES on Yahoo Finance

See Energy Stock Investors Information Report

 

Oakridge Global Energy Solutions, Inc. is an integrated, “made in USA”, energy storage solutions company that uses state-of-the-art technology to focus on making and developing advanced, high-quality cells, batteries, and power systems.

 

Their energy solutions are used in consumer, government, industrial, and military applications.

world energy solutions

The core business is in the design, development, and manufacturing of small to large format lithium ion cells, batteries, and battery systems.

Lithium-Ion Battery Energy Stock

Oakridge’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including Military, Aerospace, Marine, Industrial, Scientific and Telecom backup.

Small cap energy stocks

Oakridge’s technology team is strongly engineering driven, with core capabilities in materials, product design, process control, manufacturing technology, quality and safety.

Made in the USA Lithium-Ion Battery

 

Steve Barber: Chief Executive Officer

Steve Barber has over 30 years of experience in the international business sector with dual qualifications in science and law, specializing in international corporate finance, mergers, and acquisitions, asset acquisitions, corporate restructuring, offshore financing structures and the creation of new ventures, as well as government regulatory matters and counterterrorism risk management (especially terrorism financing restructures) in a range of international jurisdictions.

Steve holds the degrees of B.App. Sc (University of Southern Queensland), LL.B. & LL.M. (University of Adelaide), and an M.A. (Diplomacy) from Norwich University (VT).

Steve has resided in Australia, the U.S., and Canada, and his entrepreneurial approach and strength at building long term strategic alliances, coupled with his dual technical and corporate finance/law background equips him with the skill-sets necessary to bridge the gap between technical, operational, commercial, and government regulatory aspects required to create a dynamically successful, strategically focused business.

small cap US Energy Stocks

US Lithium-Ion Battery Producer

Oakridge is the poster child for the “Made in USA” movement and leads the charge in onshoring jobs and manufacturing back to America.

It manufactures hi-tech, leading edge, high quality, lithium ion batteries for high margin, niche consumer markets – golf cars, remote control cars, boats, drones and planes, home energy storage and living space power units for RVs, boats and interstate trucks, and starter motor batteries for “big boys toys” such as Harley Davidsons, jet skis, snow mobiles and boats – all cost competitive because of high quality, state of the art, automated US manufacturing techniques.

In an increasingly “unwired” world, batteries are THE recession proof product !

 

Energy Stock: USA Lithium Battery Manufacturer

Oakridge Global Energy Solutions is a publicly traded company, listed as OGES on the OTC, whose primary business is the manufacturing and marketing of products incorporating lithium battery technologies. The lithium batteries are constructed of lithium ion compounds that provide higher power, longer life, and are lighter weight than traditional batteries. These batteries can be employed in a broad range of commercial and government applications and incorporate a proprietary technology which enhances the safe operation of the battery.

 

Small Cap Energy Stocks To Buy

Best Stocks To Buy Now Investing News Show Money Info

Undervalued Energy Stock News

Oakridge Global Energy Solutions Announces it has Retained Cyril Narishkin, a Nationally Recognized Consultant in Business and Operations Management Systems

Oakridge Global Energy Solutions, Inc. Announces Joint Venture with Japan’s Toyo-System

OAKRIDGE GLOBAL ENERGY SOLUTIONS, INC. CEO, STEVE BARBER, ANNOUNCES THE PURCHASE OF $1.2 MILLION OF STATE-OF-THE-ART LITHIUM-ION BATTERY MANUFACTURING EQUIPMENT

 

 

September 6, 2016 Show:

Medical Waste Management Stock News

on Investment News Show

The September 6th show features Medical Waste Management stock

Skyline Medical, Inc. (stock symbol: SKLN) and an interview CEO Dr. Carl Schwartz

Medical Waste Management Stock News

 

See corporate site: SkylineMedical.com

Get SKLN stock quote

See Investors Information Resources

http://investors.skylinemedical.com/index.cfm

See Latest News

http://investors.skylinemedical.com/releases.cfm

Medical stocks to buy

The new standard in waste fluid management.

Skyline Medical developed the patented, FDA-approved STREAMWAY System, which simplifies and improves the management of surgical fluid for the benefit of patients, staff and the environment.

 

The revolutionary, FDA-approved STREAMWAY® System is an automated, direct-to-drain system that’s changing the way healthcare facilities collect and dispose of potentially infectious waste fluid.

 

Skyline Medical produces a fully automated, patented, FDA-cleared waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment.

 

Antiquated manual fluid handling methods that require hand carrying and emptying filled fluid canisters present an exposure risk and potential liability.

 

Skyline Medical’s STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to:

 

1) reduce overhead costs to hospitals and surgical centers;

2) improve compliance with OSHA and other regulatory agency safety guidelines;

3) improve efficiency in the operating room, and radiology and endoscopy departments, thereby leading to greater profitability; and

4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills each year in the U.S.

Medical waste management stocks

 

Medical Waste Management Stock News

Skyline Medical to Hold Business Update Conference Call on September 8th to discuss its proposed joint venture with Electronic On-Ramp and other corporate activities – See news

Listen to Call

small cap medical products stocks

 

Dr. Carl Schwartz

INTERIM PRESIDENT AND CHEIF EXECUTIVE OFFICER, DIRECTOR

Dr. Schwartz was appointed to Skyline Medical’s board of directors in March 2016, and became interim president and chief executive officer in May 2016.   He has owned and managed dental groups in Michigan, beginning with one practice in 1966, and overseeing its expansion into a 14-office practice when he left the active practice of dentistry in 1988. He currently owns two dental practices, in Burton, Mich. and Grand Blanc, Mich.

In 1988 Dr. Schwartz joined a family business, becoming chief executive officer of Plastics Research Corporation, a Flint, Mich. manufacturer of structural foam molding, a low pressure injection molding process.  While there, he led its growth from $2 million in revenues and 20 employees, to its becoming the largest manufacturer of structural foam molding products under one roof in the U.S. with more than $60 million in revenues and 300 employees when he retired in 2001.

Dr. Schwartz previously served on the board of Delta Dental Corporation of Michigan, was a member of the Michigan Advisory Board for Liberty Mutual Insurance and was a member of the Board of Trustees of the Museum of Contemporary Art in Florida.

He holds B.A. and D.D.S. degrees from the University of Detroit.

 

 

 

Undervalued Medical Stocks 

Medical Waste Management Products Stocks 

 

 

August 30, 2016 Show:

Undervalued Skin Care Products Stock

Sunscreen Product Stock

on Investment News Show

The August 30th undervalued stocks to buy and investing news show, Money Info, features:

Terry Howlett, 

President & CEO of

Skinvisible, Inc.

Stock Symbol: SKVI

Skin Products Stocks

SKINVISIBLE PHARMACEUTICALS, INC.

See Skinvisible Corporate Site — Skinvisible.com Click Here

Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance —Click Here

 

Show Also Features Texas Oil and Gas investing News

Live Interview with Tim Connolly of Texas Gulf Oil

oil investing May 2016

Tim discusses Oil Investing in September 2016

 

Sunscreen Products Stock News:

Skinvisible featured in Drug Development & Delivery journal

Skinvisible’s Kintari Launches New Addition to Product Line

See News – Skinvisible Inc., through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.

Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.

 

Skinvisible Pharmaceuticals is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing skin irritation. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. www.skinvisible.com, www.invisicare.com

Skin and Sunscreen Products Stocks

Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.

 

It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:

  • To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
  • To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
  • To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
  • To increase on-going revenues and profitability from current licensees.
  • To maximize shareholder value.

Sunscreen Products Stocks

Terry Howlett — President & Chief Executive Officer

Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.

Sunscreen Products Stocks

Sunscreen Products Stock NEWS

Skinvisible’s Kintari Launches New Addition to Product Line

Kintari’s Skincare Line Expands

April 6, 2016 Skinvisible Inc., (SKVI) through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.

Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.

SEE MORE

Anti-aging Skin care stocks

Skinvisible Expands Its Patent Portfolio with Comprehensive Acne Patent Adapalene, Retinoic Acid, Clindamycin and OTC Actives Now with IP Protection

Skinvisible Pharmaceuticals, Inc. (SKVI) a pharmaceutical research and development company with its proprietary skin delivery technology Invisicare(R), today announced that it has expanded its patent portfolio with a new patent granted by the United States Patent and Trademark Office entitled, “ACNE TREATMENT COMPOSITION AND METHODS FOR USING.”

“This patent is an important component of Skinvisible’s comprehensive intellectual property portfolio which includes sixteen patents that provide protection in the US and major international markets up to the year 2030. The granting of this patent recognizes the unique qualities of our Invisicare delivery technology. With the acne market generating over $5 billion in the U.S. last year, this new patent further enhances the value of our pipeline of products,” said Mr. Terry Howlett, President. “We are actively seeking a partner to license and advance the clinical development of our acne formulations and other prescription dermatology products.”

SEE MORE

Skinvisible’s Kintari Revolutionizes the Sunscreen Market Skinbrella(R) Officially Launched

Skinvisible Inc., through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella(R), a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.

sunscreen product stocks

 

August 16, 2016 Show:

Mining Stock News

on Investing News Show

 

August 16, 2016 Money Info Investing News show features live interview with

Phil Baker CEO of Hecla Mining (Stock Symbol:HL)

Hear a replay of Part 1 of the show:

 

Hear a replay of the Phil Baker HECLA MINING Interview:

 

Mining stock news

Corporate Web Site:  Hecla-Mining.com

Get Hecla Mining Stock Quote, Trading Charts and latest News:

USA mining stock news

Hecla Mining Company is

the largest and one of the lowest-cost U.S. silver producers,

the third largest U.S. producer of both zinc and lead,

and also a growing gold producer.

With four operating North American mines, a number of exploration properties and pre-development projects, a natural revenue hedge through the production of both precious and base metals, and its status as a growing gold producer, Hecla Mining Company is the largest primary silver producer in the U.S. – and the oldest NYSE-listed precious metals mining company in all of North America.

See Hecla Mining Investors Information Page

See Hecla Mining Investors Fact Sheet

USA mining stock news

Hecla Mining Company (NYSE:HL) is a primary leading, low-cost silver producer with operating silver mines in Alaska (Greens Creek), Idaho (Lucky Friday), and Mexico (San Sebastian) and is a gold producer with an operating mine (Casa Berardi) in Quebec, Canada. Expected 2016 silver production is 15.75 million ounces with expected gold production of 233,000 ounces.

In addition to its diversified silver and gold operating and cash-flow generating base, Hecla has a number of exploration properties and pre-development projects in six world-class silver and gold mining districts in North America. With an active exploration and development program, the company has consistently grown its reserve base for future production, with 2016 reserves totaling 175 million ounces of silver and 2.1 million ounces of gold reserves.

Established in 1891, Hecla is headquartered in Coeur d’Alene, Idaho, and has a sister office in Vancouver, B.C. The company’s common stock has been traded on the New York Stock Exchange for over 50 years.

Mining stock news

See Hecla Mining Stock News

August 9, 2016  Show

Small Cap Stocks To Buy 

Undervalued Medical Stock

on Investing News Show

 

August 9, 2016 Money Info Investing News show features live interview with small cap stock to buy:

RMS Medical Systems, Inc.

(Stock Symbol: REPR)

Chairman of the Board 

Andrew Sealfon

Medical Stocks To Buy

Hear a Replay of The Show (Interview Starts at 3 Minutes)

Part 1:

 

Part 2:

RMS Medical Products is a U.S. manufacturer of medical devices which maintains offices and manufacturing facilities in Chester, NY. They employ 60 people. For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies.

Principal products include  the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.

 

Visit the corporate website: RMSMedicalProducts.com

 

Click Here For REPR stock quotes,

trading charts and latest news releases

 

See RMS Medical Investors Information Page with financials —Click here 

 

 

The Company manufactures medical products used for infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60(R) and the newer FreedomEdge™ Syringe Infusion Pumps, RMS Precision Flow Rate Tubing(TM) and RMS HIgH-Flo(TM) Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers.

NHIA is a trade association representing the interests of entities providing infusion and specialty pharmacy products and services to home-based infusion patients.

Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.

 

Undervalued Small Cap Stocks To Buy News

 

Repro Med Systems, Inc. Posts Strong Revenue Growth,

Productivity Gains and Announces New Interim Chief Operating Officer

See News Release

 

The Freedom60 has a proprietary technology

that makes it desirable for the

delivery of medications in a wide variety of  therapies.

Medical Products Stock news

It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.

This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60.

under valued medical products stock

 

Improves  quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.

 

 

 

RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.

 

 

RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event of disasters where power is lost because it doesn’t require electricity.

 

top medical products stock

 

The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles,  which are considerably less painful when entering the skin.

 

August 2, 2016 Show:

 

Money Info Investing News Show

Show features Small Cap, undervalued

USA Battery Manufacturing Company

Live Interview with

Oakridge Global Energy Solutions:

The Only “Made in the USA” Lithium-Ion Battery

Steve Barber, Executive Chairman & CEO

 

 

Show Also Features Texas Oil and Gas investing News

Live Interview with 

Tim Connolly of Texas Gulf Oil

oil investing May 2016

Tim discusses Oil Investing in August 2016 including where to invest in Texas oil projects, oil price increase turn-around time frame and exciting opportunities created by oil price downturn.

About Tim Connolly

Tim is the Chairman, CEO, and founder of Texas Gulf Oil & Gas. Mr. Connolly is also the Managing Director and Founder of Corporate Strategies LLC, a private merchant banking firm based in Houston, Texas since 1984. Corporate Strategies portfolio companies have included interests in energy, technology, software development, defense electronics manufacturing, international nutritional products manufacturing and distribution, mobile device application development and other market segments, domestically and internationally.

Mr. Connolly has personally completed over $1 billion in transactions as principal, broker or adviser to banks, hedge funds, and investment partnerships both domestically and overseas.

 

 

Oakridge Global Energy Solutions:

Global Energy Solutions

Stock Symbol: OGES

See Corporate Site: OakG.net

See Investors Information Page with stock quotes

See OGES on Yahoo Finance

See Energy Stock Investors Information Report

 

Oakridge Global Energy Solutions, Inc. is an integrated, “made in USA”, energy storage solutions company that uses state-of-the-art technology to focus on making and developing advanced, high-quality cells, batteries, and power systems.

 

Their energy solutions are used in consumer, government, industrial, and military applications.

world energy solutions

The core business is in the design, development, and manufacturing of small to large format lithium ion cells, batteries, and battery systems.

Lithium-Ion Battery Energy Stock

Oakridge’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including Military, Aerospace, Marine, Industrial, Scientific and Telecom backup.

Small cap energy stocks

Oakridge’s technology team is strongly engineering driven, with core capabilities in materials, product design, process control, manufacturing technology, quality and safety.

Made in the USA Lithium-Ion Battery

 

Steve Barber: Chief Executive Officer

Steve Barber has over 30 years of experience in the international business sector with dual qualifications in science and law, specializing in international corporate finance, mergers, and acquisitions, asset acquisitions, corporate restructuring, offshore financing structures and the creation of new ventures, as well as government regulatory matters and counterterrorism risk management (especially terrorism financing restructures) in a range of international jurisdictions.

Steve holds the degrees of B.App. Sc (University of Southern Queensland), LL.B. & LL.M. (University of Adelaide), and an M.A. (Diplomacy) from Norwich University (VT).

Steve has resided in Australia, the U.S., and Canada, and his entrepreneurial approach and strength at building long term strategic alliances, coupled with his dual technical and corporate finance/law background equips him with the skill-sets necessary to bridge the gap between technical, operational, commercial, and government regulatory aspects required to create a dynamically successful, strategically focused business.

small cap US Energy Stocks

US Lithium-Ion Battery Producer

Oakridge is the poster child for the “Made in USA” movement and leads the charge in onshoring jobs and manufacturing back to America.

It manufactures hi-tech, leading edge, high quality, lithium ion batteries for high margin, niche consumer markets – golf cars, remote control cars, boats, drones and planes, home energy storage and living space power units for RVs, boats and interstate trucks, and starter motor batteries for “big boys toys” such as Harley Davidsons, jet skis, snow mobiles and boats – all cost competitive because of high quality, state of the art, automated US manufacturing techniques.

In an increasingly “unwired” world, batteries are THE recession proof product !

 

Energy Stock: USA Lithium Battery Manufacturer

Oakridge Global Energy Solutions is a publicly traded company, listed as OGES on the OTC, whose primary business is the manufacturing and marketing of products incorporating lithium battery technologies. The lithium batteries are constructed of lithium ion compounds that provide higher power, longer life, and are lighter weight than traditional batteries. These batteries can be employed in a broad range of commercial and government applications and incorporate a proprietary technology which enhances the safe operation of the battery.

 

Undervalued USA Energy Stock 

Investor Highlights

Oakridge Global Energy Solutions is headquartered in Melbourne Florida. We are operating a 12000 square foot battery development, a 24,000 square foot warehouse facility, and a 50,400 square foot manufacturing facility presently employing 24 full time staff members. The manufacturing plant is equipped with state of the art fabrication and manufacturing equipment for Lithium Ion batteries. The development facility is equipped with state of the art laboratory equipment including: chemistry lab, mixing operation, characterization and testing laboratories, scanning electronic microscope, and 3D color Keyence digital microscope. We have all of the necessary test and fabrication equipment to develop battery cells and systems from raw material to final product with full testing and performance validation.

 

Major Objectives

Oakridge Global Energy Solutions is continuing to develop and manufacture standard off-the-shelf products for various industries as needed to meet client’s needs. The sales force will continue to interface with existing and potential clients to pursue opportunities in commercial and government markets. The development and manufacturing facilities will be optimized for the production of product as needed to meet client delivery requirements. Additional technical and administrative staff will be hired to support development and production as needed.

 

 

Investment Highlights

 

  • Batteries made in USA using a proprietary lithium chemistry
  • Lithium batteries produced are comparable in price to traditional lead-acid

batteries, but charge faster, last longer and are much lighter.

  • Rapidly expanding workforce, and has been approved for nearly $9 million in

property tax breaks from Brevard County

  • Confirmed orders of $19.3 million backlogged in the US
  • Additional orders of $50 million in the US and Australia that are awaiting firm

delivery schedule

  • Further $110 million of orders from Japan awaiting firm delivery schedule
  • Primary shareholder (90 percent) is Precept Fund Management SPC
  • Oakridge Global Energy Solutions owns 11,000,000 shares of Leclanché S.A., a

Swiss developer and producer of energy storage systems

  • Filed for NASDAQ main board listing on July 31, 2015

 

Small Cap Energy Stocks To Buy

Undervalued Energy Stock News

Small Cap Stocks To Buy Investment News Show 

 

 

Be On The Air With Us
Call In Your Questions
888-792-1590

 

June 28 Show:

June 28th Money Info Investing News show will feature live interview with:

RMS Medical Systems, Inc.

(Stock Symbol: REPR)

Chairman of the Board 

Andrew Sealfon

Medical Stocks To Buy

Hear a replay of the show:

Andrew Sealfon Interview starts at 25 minutes

RMS Medical Products is a U.S. manufacturer of medical devices which maintains offices and manufacturing facilities in Chester, NY. They employ 60 people. For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies.

Principal products include  the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.

 

Visit the corporate website: RMSMedicalProducts.com

Click Here For REPR stock quotes,

trading charts and latest news releases

See RMS Medical Investors Information Page with financials —Click here 

Fourth quarter preliminary net revenues will exceed $3.2 million, representing a slight increase over the $3.1 million of the previous quarter.   Sales are led by the Company’s proprietary infusion products.  The Company’s fiscal year ended February 29, 2016.

Andy Sealfon, Company President and CEO commented, “The military has expressed interest in our products for utilization in emergency applications as well as use in VA hospitals.  We believe that because of our performance standards and the reliability of our products, we will provide them with great value and benefits.”

The Company manufactures medical products used for infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60(R) and the newer FreedomEdge™ Syringe Infusion Pumps, RMS Precision Flow Rate Tubing(TM) and RMS HIgH-Flo(TM) Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers.

NHIA is a trade association representing the interests of entities providing infusion and specialty pharmacy products and services to home-based infusion patients.

Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.

 

Undervalued Small Cap Medical Stock News

Repro Med Systems, Inc. Posts Strong Revenue Growth,

Productivity Gains and Announces New Interim Chief Operating Officer

See News Release

 

The Freedom60 has a proprietary technology

that makes it desirable for the

delivery of medications in a wide variety of  therapies.

Medical Products Stock news

It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.

This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60.

under valued medical products stock

 

Improves  quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.

RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.

RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event of disasters where power is lost because it doesn’t require electricity.

 

top medical products stock

The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles,  which are considerably less painful when entering the skin.

 

Undervalued Medical Stock
on Investing News Show

June 21, 2016 Show:

Undervalued Skin Products Stock

Sunscreen Product Stocks

on Investment News Show

The June 21 small cap stocks to buy and investing news show, Money Info, features:

Terry Howlett, 

President & CEO of

Skinvisible, Inc.

Stock Symbol: SKVI

Skin Products Stocks

SKINVISIBLE PHARMACEUTICALS, INC.

See Skinvisible Corporate Site — Skinvisible.com Click Here

Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance —Click Here

Listen to a Replay of the show:

The interview starts at the 24:30 Minute mark.

Once the video starts, you can hover over bottom of video to get controls and move them to the start of the interview.

Undervalued Skin Products Stock

Skinvisible Sunscreen product ad featured in USA Weekend edition right below Melanoma article.

Skinvisible featured in Drug Development & Delivery journal

Skinvisible’s Kintari Launches New Addition to Product Line

See News – Skinvisible Inc., through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.

Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.

 

Skinvisible Pharmaceuticals is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing skin irritation. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. www.skinvisible.com, www.invisicare.com

Skin and Sunscreen Products Stocks

Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.

 

It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:

  • To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
  • To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
  • To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
  • To increase on-going revenues and profitability from current licensees.
  • To maximize shareholder value.

Sunscreen Products Stocks

Terry Howlett — President & Chief Executive Officer

Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.

Sunscreen Products Stocks

Sunscreen Products Stock NEWS

Skinvisible’s Kintari Launches New Addition to Product Line

Kintari’s Skincare Line Expands

April 6, 2016 Skinvisible Inc., (SKVI) through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.

Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.

SEE MORE

Anti-aging Skin care stocks

Skinvisible Expands Its Patent Portfolio with Comprehensive Acne Patent Adapalene, Retinoic Acid, Clindamycin and OTC Actives Now with IP Protection

Skinvisible Pharmaceuticals, Inc. (SKVI) a pharmaceutical research and development company with its proprietary skin delivery technology Invisicare(R), today announced that it has expanded its patent portfolio with a new patent granted by the United States Patent and Trademark Office entitled, “ACNE TREATMENT COMPOSITION AND METHODS FOR USING.”

“This patent is an important component of Skinvisible’s comprehensive intellectual property portfolio which includes sixteen patents that provide protection in the US and major international markets up to the year 2030. The granting of this patent recognizes the unique qualities of our Invisicare delivery technology. With the acne market generating over $5 billion in the U.S. last year, this new patent further enhances the value of our pipeline of products,” said Mr. Terry Howlett, President. “We are actively seeking a partner to license and advance the clinical development of our acne formulations and other prescription dermatology products.”

SEE MORE

Skinvisible’s Kintari Revolutionizes the Sunscreen Market Skinbrella(R) Officially Launched

Skinvisible Inc., through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella(R), a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.

sunscreen product stocks

 

June 14, 2016:

The June 14th show features

USA Lithium-Ion Battery Manufacturing Company

Undervalued Energy Stock News

live interview with:

Oakridge Global Energy Solutions:

The Only “Made in the USA” Lithium-Ion Battery

Steve Barber, Executive Chairman & CEO

Global Energy Solutions

Stock Symbol: OGES

See Corporate Site: OakG.net

See Investors Information Page with stock quotes

See OGES on Yahoo Finance

See Energy Stock Investors Information Report

 

Oakridge Global Energy Solutions, Inc. is an integrated, “made in USA”, energy storage solutions company that uses state-of-the-art technology to focus on making and developing advanced, high-quality cells, batteries, and power systems.

 

Their energy solutions are used in consumer, government, industrial, and military applications.

world energy solutions

The core business is in the design, development, and manufacturing of small to large format lithium ion cells, batteries, and battery systems.

Lithium-Ion Battery Energy Stock

Oakridge’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including Military, Aerospace, Marine, Industrial, Scientific and Telecom backup.

Small cap energy stocks

Oakridge’s technology team is strongly engineering driven, with core capabilities in materials, product design, process control, manufacturing technology, quality and safety.

Made in the USA Lithium-Ion Battery

 

Steve Barber: Chief Executive Officer

Steve Barber has over 30 years of experience in the international business sector with dual qualifications in science and law, specializing in international corporate finance, mergers, and acquisitions, asset acquisitions, corporate restructuring, offshore financing structures and the creation of new ventures, as well as government regulatory matters and counterterrorism risk management (especially terrorism financing restructures) in a range of international jurisdictions.

Steve holds the degrees of B.App. Sc (University of Southern Queensland), LL.B. & LL.M. (University of Adelaide), and an M.A. (Diplomacy) from Norwich University (VT).

Steve has resided in Australia, the U.S., and Canada, and his entrepreneurial approach and strength at building long term strategic alliances, coupled with his dual technical and corporate finance/law background equips him with the skill-sets necessary to bridge the gap between technical, operational, commercial, and government regulatory aspects required to create a dynamically successful, strategically focused business.

small cap US Energy Stocks

US Lithium-Ion Battery Producer

Oakridge is the poster child for the “Made in USA” movement and leads the charge in onshoring jobs and manufacturing back to America.

It manufactures hi-tech, leading edge, high quality, lithium ion batteries for high margin, niche consumer markets – golf cars, remote control cars, boats, drones and planes, home energy storage and living space power units for RVs, boats and interstate trucks, and starter motor batteries for “big boys toys” such as Harley Davidsons, jet skis, snow mobiles and boats – all cost competitive because of high quality, state of the art, automated US manufacturing techniques.

In an increasingly “unwired” world, batteries are THE recession proof product !

 

Energy Stock: USA Lithium Battery Manufacturer

Oakridge Global Energy Solutions is a publicly traded company, listed as OGES on the OTC, whose primary business is the manufacturing and marketing of products incorporating lithium battery technologies. The lithium batteries are constructed of lithium ion compounds that provide higher power, longer life, and are lighter weight than traditional batteries. These batteries can be employed in a broad range of commercial and government applications and incorporate a proprietary technology which enhances the safe operation of the battery.

 

Undervalued USA Energy Stock 

Investor Highlights

Oakridge Global Energy Solutions is headquartered in Melbourne Florida. We are operating a 12000 square foot battery development, a 24,000 square foot warehouse facility, and a 50,400 square foot manufacturing facility presently employing 24 full time staff members. The manufacturing plant is equipped with state of the art fabrication and manufacturing equipment for Lithium Ion batteries. The development facility is equipped with state of the art laboratory equipment including: chemistry lab, mixing operation, characterization and testing laboratories, scanning electronic microscope, and 3D color Keyence digital microscope. We have all of the necessary test and fabrication equipment to develop battery cells and systems from raw material to final product with full testing and performance validation.

 

Major Objectives

Oakridge Global Energy Solutions is continuing to develop and manufacture standard off-the-shelf products for various industries as needed to meet client’s needs. The sales force will continue to interface with existing and potential clients to pursue opportunities in commercial and government markets. The development and manufacturing facilities will be optimized for the production of product as needed to meet client delivery requirements. Additional technical and administrative staff will be hired to support development and production as needed.

 

 

Investment Highlights

 

  • Batteries made in USA using a proprietary lithium chemistry
  • Lithium batteries produced are comparable in price to traditional lead-acid

batteries, but charge faster, last longer and are much lighter.

  • Rapidly expanding workforce, and has been approved for nearly $9 million in

property tax breaks from Brevard County

  • Confirmed orders of $19.3 million backlogged in the US
  • Additional orders of $50 million in the US and Australia that are awaiting firm

delivery schedule

  • Further $110 million of orders from Japan awaiting firm delivery schedule
  • Primary shareholder (90 percent) is Precept Fund Management SPC
  • Oakridge Global Energy Solutions owns 11,000,000 shares of Leclanché S.A., a

Swiss developer and producer of energy storage systems

  • Filed for NASDAQ main board listing on July 31, 2015

 

Small Cap Energy Stocks To Buy

Best Stocks To Buy Now Investing News Show Money Info

Undervalued Energy Stock News

 

 

Small Cap Stocks To Buy Investment News Show Replays

 

Money Info Show

Replay Archives

 

Hear Replays of

June 2016 to April 2016 Shows

HERE

 

Hear Replays of

March 2016 to January 2016 Shows

HERE

Hear Replays of 

December 2015 to October 2015 Shows

Click Here

Hear Replays of 

December 2015 to October 2015 Shows

Click Here

 

Hear Replays of 

September 2015 to June 2015 Shows

Click Here

 

Hear Replays of 

June 2015 to April 2015 Shows

Click Here   

investment news show

The Princeton Research Money Info Show features

where to invest now,

stock market, business, economy and

financial investment news.

 

Stock Options Trading Alerts Update:

In order to make more investors aware of the exceptional gains we are producing with our Options Trading Alerts Service we are offering (for a very limited time) free sample trade alerts and sample issues of the Market Strategies Newsletter.

See http://www.princetonresearch.com/options-trading.htm to get in today.

Money Info Investment News Show